Geographical differences in Chlamydia trachomatis testing in 15-29 year-olds in Tasmania: Findings from a statewide laboratory data linkage study

2016 ◽  
Vol 25 (3) ◽  
pp. 182-184
Author(s):  
Nicola Stephens ◽  
David Coleman ◽  
Kelly Shaw ◽  
Alison Venn
Sexual Health ◽  
2017 ◽  
Vol 14 (3) ◽  
pp. 261 ◽  
Author(s):  
Nicola Stephens ◽  
David Coleman ◽  
Kelly Shaw ◽  
Maree O'Sullivan ◽  
Alistair McGregor ◽  
...  

Background Chlamydia re-infection increases the likelihood of adverse long-term sequelae. Clinical guidelines recommend retesting at 3–12 months for individuals with positive results, to detect re-infections. Retesting and test positivity levels were measured in young people who previously tested positive for chlamydia infection. Methods: All chlamydia tests conducted during 2012–13 in Tasmanian residents aged 15–29 years were linked. Retesting and retest positivity rates were calculated by sex, age, socioeconomic indicators and test timeframe. Results: Retesting rates were higher in females than males at 3 months (14.5%, n = 242/1673 vs 10%, n = 71/721) (P < 0.01) and 12 months (27%, 265/968 vs 24%, 98/410) (P = 0.24). The retesting rate was higher in females living in areas of most disadvantage (35.5%, 154/434) compared with areas of middle and least disadvantage (26% 139/534) (P < 0.01). Males were more likely than females to retest positive at 3 months (35%, 25/71 vs 23%, 55/242) (P < 0.01); retest positivity at 12 months was 32% in both sexes (males 98/140; females 265/968). Retest positivity was higher in males living in areas of least disadvantage (43%, 3/7) compared with middle (24%, 16/67) (P = 0.27) and most (27%, 10/37) (P = 0.09); and higher in females living in areas of least disadvantage (39%, 7/18) compared with middle (24%, 29/121) (P < 0.01) and most (31%, 48/154) (P = 0.02). Conclusions: Retesting rates are low in Tasmania and retest positivity is high, reinforcing the importance of promoting safer sex practices, partner notification and treatment, and retesting.


2018 ◽  
Author(s):  
Francisco Schneuer ◽  
Elizabeth Milne ◽  
Sarra E. Jamieson ◽  
Gavin Pereira ◽  
Michele Hansen ◽  
...  

Author(s):  
Jia-Li Feng ◽  
Suzanne C. Dixon-Suen ◽  
Susan J. Jordan ◽  
Penelope M. Webb

2021 ◽  
pp. bmjspcare-2020-002708
Author(s):  
Katharina Diernberger ◽  
Xhyljeta Luta ◽  
Joanna Bowden ◽  
Marie Fallon ◽  
Joanne Droney ◽  
...  

BackgroundPeople who are nearing the end of life are high users of healthcare. The cost to providers is high and the value of care is uncertain.ObjectivesTo describe the pattern, trajectory and drivers of secondary care use and cost by people in Scotland in their last year of life.MethodsRetrospective whole-population secondary care administrative data linkage study of Scottish decedents of 60 years and over between 2012 and 2017 (N=274 048).ResultsSecondary care use was high in the last year of life with a sharp rise in inpatient admissions in the last 3 months. The mean cost was £10 000. Cause of death was associated with differing patterns of healthcare use: dying of cancer was preceded by the greatest number of hospital admissions and dementia the least. Greater age was associated with lower admission rates and cost. There was higher resource use in the urban areas. No difference was observed by deprivation.ConclusionsHospitalisation near the end of life was least frequent for older people and those living rurally, although length of stay for both groups, when they were admitted, was longer. Research is required to understand if variation in hospitalisation is due to variation in the quantity or quality of end-of-life care available, varying community support, patient preferences or an inevitable consequence of disease-specific needs.


Author(s):  
Amminadab L. Eliakundu ◽  
Dominique A. Cadilhac ◽  
Joosup Kim ◽  
Nadine E. Andrew ◽  
Christopher F. Bladin ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document